Thousands to benefit as weight loss drug Mounjaro approved for new use

Weight-loss drug Mounjaro is approved to treat sleep apnoea in Australia and the US - (Alamy/PA)

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The TGA has indicated Mounjaro can be used to treat moderate to severe obstructive sleep apnoea in adults with obesity (a body mass index of 30 or above).